1. |
Boye K, Maelandsmo GM. S100A4 and metastasis: a small actor playing many roles[J]. Am J Pathol, 2010, 176(2): 528-535.DOI:10.2353/ajpath.2010.090526.
|
2. |
Saleem M, Kweon MH, Johnson JJ, et al. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9[J]. Proc Natl Acad Sci USA, 2006, 103(40): 14825-14830.
|
3. |
Smith LE, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse[J]. Invest Ophthalmol Vis Sci, 1994, 35(1): 101-111.
|
4. |
Chen YY, Liu SL, Hu DP, et al. N-methyl-N-nitrosourea-induced retinal degeneration in mice[J]. Exp Eye Res, 2014, 121: 102-113. DOI:10.1016/j.exer.2013.12.019.
|
5. |
Ghoul A, Serova M, Astorgues-Xerri L, et al. Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells[J]. Cancer Res, 2009, 69(10):4260-4269. DOI: 10.1158/0008-5472.CAN-08-2837.
|
6. |
Malashkevich VN, Varney KM, Garrett SC, et al. Structure of Ca2+-bound S100A4 and its interaction with peptides derived from nonmuscle myosin-ⅡA[J]. Biochemistry, 2008, 47(18): 5111-5126. DOI:10.1021/bi702537s.
|
7. |
Kim EJ, Helfman DM. Characterization of the metastasis-associated protein, S100A4:roles of calcium binding and dimerization in cellular localization and interaction with myosin[J]. J Biol Chem, 2003, 278(32): 30063-30073.
|
8. |
Grigorian M, Andresen S, Tulchinsky E, et al. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction[J]. J Biol Chem, 2001, 276(25): 22699-22708.
|
9. |
Peshavariya HM, Liu GS, Chang CW, et al. Prostacyclin signaling boosts NADPH oxidase 4 in the endothelium promoting cytoprotection and angiogenesis[J]. Antioxid Redox Signal, 2014, 20(17): 2710-2725.
|
10. |
Darashchonak N, Koepsell B, Bogdanova N, et al. Adenosine A2B receptors induce proliferation, invasion and activation of cAMP response element binding protein (CREB) in trophoblast cells[J]. BMC Pregnancy Childbirth, 2014, 14: 2. DOI: 10.1186/1471-2393-14-2.
|
11. |
Barresi V, Branca G, Caffo M, et al. p-CREB expression in human meningiomas: correlation with angiogenesis and recurrence risk[J]. J Neurooncol, 2015, 122(1): 87-95. DOI: 10.1007/s11060-014-1706-9.
|
12. |
Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB[J]. Nat Rev Mol Cell Biol, 2001, 2(8): 599-609.
|
13. |
Meller R, Minami M, Cameron JA, et al. CREB-mediated Bcl-2 protein expression after ischemic preconditioning[J]. J Cereb Blood Flow Metab, 2005, 25(2): 234-246.
|
14. |
Boland K, Flanagan L, Prehn JH. Paracrine control of tissue regeneration and cell proliferation by Caspase-3[J]. Cell Death Dis, 2013, 4: 725. DOI: 10.1038/cddis.2013.250.
|
15. |
Nassar A, Lawson D, Cotsonis G, et al. Survivin and caspase-3 expression in breast cancer: correlation with prognostic parameters, proliferation, angiogenesis, and outcome[J]. Appl Immunohistochem Mol Morphol, 2008, 16(2): 113-120.
|
16. |
Volm M, Mattern J, Koomagi R. Inverse correlation between apoptotic (Fas ligand, caspase-3) and angiogenic factors (VEGF, microvessel density) in squamous cell lung carcinomas[J]. Anticancer Res, 1999, 19(3A): 1669-1671.
|